[Effects of cerebral gangliosides on gastric secretory-motor changes in subjects with diabetes mellitus. II].
D003920:Diabetes Mellitus / Q000503:physiopathology*; D005260:Female; D005732:Gangliosides / Q000627:therapeutic use*; D005746:Gastric Emptying / Q000187:drug effects*; D005750:Gastric Juice / Q000378:metabolism*; D006801:Humans; D008297:Male; D008995:Monoamine Oxidase / Q000378:metabolism
D005732:Gangliosides; D008995:Monoamine Oxidase
Effetti dei gangliosidi cerebrali su alterazioni secreto-motorie gastriche in soggetti con diabete mellito. Nota II.